● The report showed a steepRevenuedecline, a significant deterioration for the customer-experience and BPO company.
● Tvardi Therapeutics trades near 52-week lows, reflecting the impact of an earlier clinical setback.
● UWM Holdings reported a second-quarter net loss of $451.9 million, one of the roughest stretches in its five-year run as a public company.
● OPAL Fuels shares fell roughly 6% to about $2.46 on August 11, 2026 following second-quarter 2026 results released August 10.
● RLX Technology fell on August 14, 2026 after reporting second-quarter results that beat onRevenuegrowth.
● The ONE Group Hospitality closed at $1.83 on August 14, 2026, up 1.67% on the day but still hovering near its 52-week low of $1.65.
● Tenax Therapeutics shares collapsed roughly 85% on August 10, 2026, one of the steepest single-day declines in the sector this year.
● Montauk Renewables returned to profitability in the second quarter of 2026, reporting $54.0 million in revenue.
● Shares fell roughly 14% the same day, as the strongVolumewas overshadowed byMarginconcerns.
● Neumora Therapeutics confirmed in a June 2026 release that navacaprant is discontinued, its once-flagship depression drug.